What is MetLife Inc's share price today?
MetLife Inc (MET) share price today is $98.81 as of October 24, 2026 at 1:29 AM IST. The stock touched a day high of $103.00 and a day low of $97.91.What exchange does MetLife Inc stock trade on, and under what ticker symbol?
MetLife Inc stock trades on NYSE under the ticker symbol MET.What is MetLife Inc's market capitalization?
MetLife Inc's market capitalization is $64.93B as of October 24, 2026 at 1:29 AM IST.What is MetLife Inc's price-to-earnings (P/E) ratio?
MetLife Inc's price-to-earnings (P/E) ratio is 19.57 as of October 23, 2026.What is MetLife Inc's price-to-book (P/B) ratio?
MetLife Inc's price-to-book (P/B) ratio is 2.22 as of October 23, 2026.Does MetLife Inc pay a dividend, and what is its dividend yield?
Yes, MetLife Inc pays a dividend, with a current dividend yield of 2.27%.Can Indian investors buy MetLife Inc shares?
Yes, You can buy MetLife Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in MetLife Inc shares from India?
Indian investors can buy MetLife Inc shares in three steps: 1. Search MetLife Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from MetLife Inc shares for Indian investors?
Since MetLife Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in MetLife Inc shares via Tickertape?
Indian investors can start investing in MetLife Inc (MET) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1011 shares at the current price of $98.81.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 18 analysts reports
Price Upside
+8.91%
Earnings Growth
+16%
Rev. Growth
+3.37%
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
The next fiscal year's mean estimate implies 3.37% growth, versus a trailing 3-year CAGR of 4.29%.
All values in $ Billion
All values in $ Billion
Earnings Per Share Forecast
Earnings Per Share Forecast
The next fiscal year's mean estimate implies 16.00% growth, versus a trailing 3-year CAGR of 8.80%.
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15.90 | 17.49 | 18.29 | 18.44 | 18.26 | 17.17 | 16.88 | 23.81 | 19.07 | 18.87 |
| Gross Profit | 4.49 | 4.38 | 5.44 | 4.86 | 4.72 | 4.54 | 2.93 | 7.27 | 7.10 | 2.78 |
| Net Income | 0.86 | 0.94 | 1.34 | 1.27 | 0.94 | 0.72 | 0.89 | 0.80 | 1.18 | 0.73 |
| Net Profit Margin | 5.45% | 5.40% | 7.33% | 6.89% | 5.17% | 4.24% | 5.30% | 3.39% | 6.21% | 3.89% |
Peers
Peers & Comparison
Peers & Comparison
Financial ServicesInsurance - Life
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| MetLife Inc | 19.57 | 2.22 | 0.50 |
| Berkshire Hathaway Inc | 13.60 | 1.44 | 9.68 |
| Manulife Financial Corp | 16.95 | 2.19 | 0.87 |
The 12-month consensus target implies 8.91% growth, versus a trailing 3-year CAGR of 21.85%.